Infusion Pumps Market: By Type (Insulin Pumps, Volumetric Infusion Pumps, Ambulatory Infusion Pumps, Disposable Infusion Pumps, and Others), By Indication (Chemotherapy/Oncology, Diabetes, Hematology, Pediatrics, and Others), By Technology (Traditional Infusion Pumps and Specialty Infusion Pumps), and By Geography (North America, Europe, Asia Pacific, Latin America, and MEA), and Forecast to 2030.

The global infusion pumps market size was valued at USD 17.5 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 7.5% from 2024 to 2030 to reach USD 29 billion in 2030. The Infusion Pumps Market refers to the global market for medical devices known as infusion pumps. These devices are used to deliver fluids, such as medications or nutrients, into a patient's body in a controlled manner. Infusion pumps are used to administer precise amounts of medications, including chemotherapy drugs, antibiotics, and pain medications. They are crucial for delivering fluids, electrolytes, and nutrients intravenously to patients who cannot take these orally. The infusion pump market is currently growing rapidly due to advancements in technology, and an uptick in chronic disease cases.

By integrating connectivity solutions and IoT, healthcare providers can now remotely monitor patients more effectively, improving treatment outcomes. Moreover, the rising demand for personalized medicine has spurred the need for infusion pumps that offer customizable therapy options and adjustable dosing, which in turn is fueling market growth. Government initiatives are significantly contributing to the expansion of the market. Many countries are boosting their healthcare expenditures to enhance medical access for their populations, which is expected to drive greater demand for medical devices like infusion pumps. However, some of the restraints in the infusion pump market include stringent regulatory requirements for device approval, potential risks associated with device malfunctions or misuse, and the high initial costs of advanced technological devices limiting affordability for some healthcare providers and patients.

Infusion Pumps Market Key Developments:

• In August 2023, ICU Medical received FDA clearance for the Plum Duo™ infusion pump and LifeShield™ infusion safety software for medication delivery and safety.
• In July 2023, KORU Medical Systems announced the 510(K) Submission for Freedom60® Infusion System with Hizentra® 50 mL Prefilled Syringes.
• In March 2023, Mary Lanning Healthcare entered into a collaboration with Epic Systems to enhance medication safety by integrating its Epic EHR with IV pumps.